MK0653C

· Organon and Co

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0653C, covering 2014-02-12 to 2014-02-12. Get the full timeline:

Most recent: Clinical Trial Update: MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162) [Phase 3]